Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI (Nerixia)

This study has been completed.
Sponsor:
Collaborators:
Ospedale Maggiore Policlinico Mangiagalli e Regina Elena
Ospedale "Perrino" Brindisi
Reggio Calabria
Azienda Ospedaliera Villa Sofia
Azienda Ospedaliera V. Cervello
Università di Ferrara
Second University of Naples
Information provided by:
Ente Ospedaliero Ospedali Galliera
ClinicalTrials.gov Identifier:
NCT01140321
First received: June 7, 2010
Last updated: June 8, 2010
Last verified: June 2010